Dose+ is an AI-powered solution designed to support plan optimisation for prostate and pelvic lymph node radiotherapy. Using machine learning techniques to generate patient-specific dose predictions, Dose+ helps radiation oncology professionals plan more efficiently. By analysing individual anatomy, it delivers tailored 3D dose estimates that align with clinical best practices.
Dose+ creates clinically achievable VMAT dose distributions from CT images and structure sets using a simple DICOM transfer. These 3D dose distributions can be imported into any DICOM-compliant treatment planning system, offering a strong starting point for plan refinement. By improving efficiency and consistency, Dose+ helps maintain high plan quality across different planning scenarios.
Specialised AI Models for Prostate and Pelvic Radiotherapy
Dose+ features two specialised AI models for prostate and pelvic lymph node radiotherapy, clinically validated across multiple institutions. The prostate model supports inverse planning for localised prostate cancer, while the pelvic LN model assists in cases involving lymph nodes. Both models generate achievable VMAT-style dose distributions, serving as personalised starting points in defining objectives before plan optimisation.
The system supports all standard fractionation schemes, including simultaneous integrated boost techniques, requiring only standard anatomical structures with associated target dose for prediction. With consistent performance across cases, the models do not require local tuning or adjustments, allowing for immediate clinical implementation and improved workflow efficiency.